Sleek Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 23-06-2024
- Paid Up Capital ₹ 1.50 Cr
as on 23-06-2024
- Company Age 19 Year,
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2020)
- Profit -369.52%
(FY 2020)
- Ebitda 93.39%
(FY 2020)
- Net Worth -0.18%
(FY 2020)
- Total Assets -0.00%
(FY 2020)
About Sleek Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Paritosh Pandey, Ashutosh Pandey, Mahendra Panday, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232UP2005PTC031146
- Company No.
031146
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Dec 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationUttar Pradesh, Uttar Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sleek Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahendra Panday  | Managing Director | 26-Dec-2005 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paritosh Pandey | Director | 30-Jun-2014 | Current |
| Ashutosh Pandey | Director | 26-Dec-2005 | Current |
| Surendra Pandey | Director | 26-Dec-2005 | Current |
Financial Performance of Sleek Laboratories.
Sleek Laboratories Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 369.52% decrease in profit. The company's net worth dipped by a decrease of 0.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sleek Laboratories?
In 2020, Sleek Laboratories had a promoter holding of 8.67% and a public holding of 91.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cadre Infraventures Private LimitedActive 7 years 4 monthsParitosh Pandey and Ashutosh Pandey are mutual person
- Trimark Business Private LimitedActive 2 years 9 months
Mahendra Panday and Surendra Pandey are mutual person
- Sleek Corporation Private LimitedActive 15 years 5 months
Mahendra Panday and Surendra Pandey are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sleek Laboratories?
Unlock and access historical data on people associated with Sleek Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sleek Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sleek Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
